ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: In accordance with this, circulating ANGPTL8 levels also showed specific changes in a variety of metabolic diseases, including diabetes, obesity, non-alcoholic fatty liver disease (NAFLD), metabolic syndrome, polycystic ovary syndrome (PCOS) and so on [9–13].